NCT04376593View on ClinicalTrials.gov

PET/CT Imaging in COVID-19 Patients

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
COVID-19SARS-CoV-2 Infection
Interventions
DRUG

18F-αvβ6-BP

Subjects will be injected once per imaging session (a maximum of 3 imaging sessions) with up to 10 mCi (±20%) of 18F-αvβ6-BP as a rapid intravenous bolus (within 30 secs).

Trial Locations (1)

95817

University of California Davis, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER